Kashif Rafiq Zahid
Biochemistry, Genetics and Molecular Biology · Indiana University
Publications
40
Citations
653
Est. group size
—
Recurring co-author estimate
Active years
14
Publishing since 2013
Kashif Rafiq Zahid studies the molecular biology of cancer, focusing on genes and proteins that influence how tumors grow, spread, and respond to treatment. The work spans cancers such as glioma, liver, esophageal, breast, and pancreatic cancer, and includes research on how immune cells interact with tumors as well as biosensing methods for detecting cancer-related molecules.
Publication activity increased sharply around 2022 and has remained moderately active since, averaging about 4.6 papers per year over the last five years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- SNRPD2-dependency Fuels an Oncogenic Alternative Splicing Repertoire Driving Disease Aggressiveness in Glioma
Cancer Genomics & Proteomics · 2026
- Tackling cancer stemness with nanotechnology in the era of precision medicine
BMEMat · 2026
- IL1B-Expressing Exhausted CD4 <sup>+</sup> T Cells Are Associated With Disease Aggressiveness in Glioblastoma
Cancer Genomics & Proteomics · 2026
- High Kin17 expression is correlated with metastasis and prognosis of esophageal squamous cell carcinoma
The International Journal of Biological Markers · 2025
- Cystic Fibrosis: Understanding Cystic Fibrosis Transmembrane Regulator Mutation Classification and Modulator Therapies
Advances in respiratory medicine · 2024
- β-Lapachone promotes the recruitment and polarization of tumor-associated neutrophils (TANs) toward an antitumor (N1) phenotype in NQO1-positive cancers
OncoImmunology · 2024
- PRIM2: A Marker of MYC-driven Hyper-proliferation, Disease Progression, Tumor Aggressiveness and Poor Survival in Glioma Patients
Cancer Genomics & Proteomics · 2024
- KIN17 functions in DNA damage repair and chemosensitivity by modulating RAD51 in hepatocellular carcinoma
Human Cell · 2024
- Hypoxia-driven ncRNAs in breast cancer
Frontiers in Oncology · 2023
- Augmented Concentration of Isopentyl-Deoxynyboquinone in Tumors Selectively Kills NAD(P)H Quinone Oxidoreductase 1-Positive Cancer Cells through Programmed Necrotic and Apoptotic Mechanisms
Cancers · 2023
- Structure and functions of Mer, an innate immune checkpoint
Frontiers in Immunology · 2023
- Isopentyl-Deoxynboquinone Induces Mitochondrial Dysfunction and G2/M Phase Cell Cycle Arrest to Selectively Kill <i>NQO1</i> -Positive Pancreatic Cancer Cells
Antioxidants and Redox Signaling · 2023
- Current methods for the detection of glypican-3
Analytical Methods · 2023
- Alpha-1-antichymotrypsin as a novel biomarker for diagnosis, prognosis, and therapy prediction in human diseases
Cancer Cell International · 2022
- Neutrophils: Musketeers against immunotherapy
Frontiers in Oncology · 2022
- Frontiers in Oncology×3
- Cancer Genomics & Proteomics×3
- SSRN Electronic Journal×3
- Cancer Cell International×2
- Frontiers in Plant Science×1
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile